Racial Differences in Time to Treatment for Melanoma Patients

The incidence of cutaneous melanoma continues to rise as an estimated 2.3% of Americans are diagnosed with the disease per year. Research has shown that the frequency of dermatology visits can reduce adverse events, mortality, and unnecessary hospitalizations for melanoma patients. Time of detection and time to treatment are essential factors in guaranteeing the best …

Growing Evidence of Increased Cancer Risk in Psoriasis Patients

Often triggered by stress, infections, and certain medications, the chronic inflammatory skin condition psoriasis affects up to 125 million patients worldwide. The skin disorder has been linked to decreased quality of life, along with an increased risk of comorbid conditions. In recent years, the association between psoriasis and risk of cancer has been controversial with …

The Role of Gut Microbiome in Psoriasis

The body of clinical literature concerning psoriasis is continuously growing as the disease’s many unsolved mysteries continue to puzzle investigators. While research has yet to uncover a cure for psoriasis, significant developments in recent years have enabled the development of therapies that can drastically mitigate associated symptoms and improve patient quality of life. A new …

The Dermatological Symptoms of COVID-19

As more clinical and anecdotal evidence comes to light, the list of potential COVID-19 symptoms continues to grow. Previously associated with fever, a persistent dry cough, and acute respiratory distress, the virus has now been linked to a host of other symptoms including dermatologic ones. While viruses are often associated with rashes and other cutaneous …